We are live on
!
Find out more
AAM
Alpine Associates Management Portfolio holdings
AUM
$1.7B
1-Year Est. Return
97.55%
This Fund
S&P 500
This Quarter
Est. Return
+16.87%
1 Year Est. Return
+97.55%
3 Year Est. Return
+368.61%
5 Year Est. Return
+1,313.28%
10 Year Est. Return
+23,749.22%
AUM
$1.87B
AUM Growth
-$34.2M
(-1.8%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-7.81%
Top 10 Holdings %
Top 10 Hldgs %
56.69%
Holding
69
New
24
Increased
15
Reduced
10
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$110M |
| 2 |
MAG
MAG Silver
MAG
|
+$45.2M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$42.2M |
| 4 |
COOP
Mr. Cooper
COOP
|
+$33M |
| 5 |
INFA
Informatica
INFA
|
+$28.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$169M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$94.9M |
| 3 |
VRN
Veren
VRN
|
+$53.5M |
| 4 |
PYCR
Paycor HCM, Inc. Common Stock
PYCR
|
+$49.9M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$49.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.04% |
| 2 | Technology | 18.01% |
| 3 | Energy | 14.94% |
| 4 | Industrials | 12.73% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNB
26
DELISTED
Dun & Bradstreet
DNB
| $23.4M | 1.25% |
2,568,947
+1,558,347
| +154% | +$14M |
|
|
SKX
27
DELISTED
Skechers
SKX
| $22.6M | 1.21% |
+358,900
| New | +$20.6M |
|
|
AVDX
28
DELISTED
AvidXchange
AVDX
| $22.1M | 1.18% |
+2,255,100
| New | +$20.3M |
|
|
WBA
29
DELISTED
Walgreens Boots Alliance
WBA
| $20M | 1.07% |
1,740,581
+1,322,250
| +316% | +$14.7M |
|
|
AGS
30
DELISTED
PlayAGS
AGS
| $19.3M | 1.03% |
1,544,344
-10,250
| -0.7% | -$125K |
|
|
FL
31
DELISTED
Foot Locker
FL
| $18.5M | 0.99% |
+755,450
| New | +$13.7M |
|
|
TGI
32
DELISTED
Triumph Group
TGI
| $17.5M | 0.93% |
680,271
-1,729
| -0.3% | -$44.1K |
|
|
ETWO
33
DELISTED
E2open Parent Holdings
ETWO
| $14.1M | 0.75% |
+4,374,650
| New | +$11.5M |
|
34
Shutterstock
SSTK
$223M
| $13.9M | 0.74% |
731,086
+131,131
| +22% | +$2.31M |
|
|
CCRN
35
DELISTED
Cross Country Healthcare
CCRN
| $12.9M | 0.69% |
985,683
-266,841
| -21% | -$3.67M |
|
|
PRA
36
DELISTED
ProAssurance
PRA
| $12.5M | 0.67% |
548,740
+327,440
| +148% | +$7.56M |
|
|
GTLS
37
DELISTED
Chart Industries
GTLS
| $12.1M | 0.65% |
+73,751
| New | +$10.8M |
|
|
CTLP
38
DELISTED
Cantaloupe
CTLP
| $12.1M | 0.64% |
+1,096,700
| New | +$9.49M |
|
39
Surgery Partners
SGRY
$2.1B
| $12M | 0.64% |
540,025
-30,050
| -5% | -$668K |
|
|
SAGE
40
DELISTED
Sage Therapeutics
SAGE
| $11.6M | 0.62% |
+1,273,348
| New | +$9.37M |
|
|
TXNM
41
TXNM Energy Inc
TXNM
$6.38B
| $11M | 0.59% |
+194,800
| New | +$10.6M |
|
|
CVAC
42
DELISTED
CureVac
CVAC
| $10.7M | 0.57% |
+1,971,175
| New | +$7.82M |
|
|
INZY
43
DELISTED
Inozyme Pharma
INZY
| $8.75M | 0.47% |
+2,188,100
| New | +$5.42M |
|
|
VIGL
44
DELISTED
Vigil Neuroscience
VIGL
| $8.7M | 0.46% |
+1,094,900
| New | +$4.91M |
|
|
DCH
45
CALL
Dauch Corp
DCH
$1.38B
| $6.19M | 0.33% |
+1,516,900
| New | +$6.11M |
|
46
Brighthouse Financial
BHF
$3.55B
| $5.23M | 0.28% |
+97,175
| New | +$5.46M |
|
47
TaskUs
TASK
$582M
| $4.37M | 0.23% |
+260,757
| New | +$3.97M |
|
|
GENVR
48
Gen Digital Inc Contingent Value Rights
GENVR
| $3.1M | 0.17% |
+379,348
| New | +$2.67M |
|
|
MRC
49
DELISTED
MRC Global
MRC
| $2.25M | 0.12% |
+164,300
| New | +$1.98M |
|
|
CVE.WS
50
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| $1.13M | 0.06% |
127,258
| – | – |
|
Similar funds
RSCM
ACM
BCM
PP
FDP
GAM
FACM
TCBWMS
Alpine Associates Management's Q2 2025 Portfolio in Review
As of Q2 2025, Alpine Associates Management held 69 positions worth $1.87B, down 1.8% from $1.91B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Alpine Associates Management withdrew a net $146M in Q2 2025, closing 19 positions and reducing 10 holdings. Its most notable exit was Discover Financial Services, an estimated $169M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
Against the trend, Alpine Associates Management opened a new position in Blueprint Medicines worth $136M.
- Alpine Associates Management's largest Q2 2025 buy was Blueprint Medicines: 1,060,307 shares worth $136M.
- Alpine Associates Management added most to SpringWorks Therapeutics in Q2 2025, an estimated $42.2M increase.
- Alpine Associates Management's biggest Q2 2025 reduction was Spirit AeroSystems, cutting an estimated $4.74M.
- Alpine Associates Management fully exited Discover Financial Services in Q2 2025, selling an estimated $169M.
- Alpine Associates Management's ten largest holdings make up 57% of its $1.87B portfolio in Q2 2025.
- Alpine Associates Management opened 24 new positions and closed 19 in Q2 2025.
- Alpine Associates Management's portfolio value fell 1.8% quarter-over-quarter to $1.87B.
Based on Alpine Associates Management's 13F filing for Q2 2025, filed 5 Aug 2025.